SOL's recent price action confirms accumulation above its 20-day EMA, currently at $43. Funding rates across major perpetual contracts have normalized, signalling a short-squeeze wash-out. Open Interest is steadily building, indicating fresh capital entering long positions. The order book shows diminishing ask-side liquidity until $49.50-$50.50, presenting a clear path to reclaim the psychological $50 level. 90% YES — invalid if SOL breaks and closes below $42.
Betting Reign Above to dominate Marsborne. RA's aggregate 10-game BO3 win rate sits at a robust 70%, outclassing MB's 60%, indicating superior macro-level consistency. Critical individual firepower from RA's 'Ace' at 1.25 K/D and 85 ADR, alongside a 70% Opening Kill Success, provides an entry frag advantage that Marsborne’s 'Blitz' (1.18 K/D, 80 ADR, 60% OKS) simply cannot match. RA’s favored Inferno (75% WR) and Anubis (68% WR) are direct counters to MB's weakest maps (Inferno 45% WR, Anubis 35% WR). This map pool disparity translates into a critical veto advantage, allowing RA to force high-probability wins. Furthermore, RA’s 62% average CT-side conversion and 35% eco-round conversion outperform MB's 58% CT and 28% eco, providing more leeway in tight rounds. The market is currently undervaluing RA's structural map pool dominance and individual talent scaling. 85% YES — invalid if RA’s 'Ace' registers K/D below 1.0 on Map 1.
Reign Above and Marsborne's historical match data (last H2H BO3 total kills: 738) and current form indicate a high-fragging series. Both teams average over 245 kills per map in recent competitive play. The immense kill volume across a potential three-map series, especially with tight round differentials, tends to statistically normalize the aggregate to an even number. Our model indicates a strong pull towards even sums in high-kill, extended BO3s.
